P04439 (HLAA_HUMAN) Homo sapiens (Human)

HLA class I histocompatibility antigen, A alpha chain UniProtKBInterProSTRINGInteractive Modelling

365 aa; Sequence (Fasta) ; (Isoform 2; ) Identical sequences: Homo sapiens: B1PKY1

Sequence Features

Add
 3V -> I (in allele A*34:01) VAR_082315
 5A -> P (in allele A*80:01) VAR_082316
 10L -> V (in allele A*02:01, allele A*02:05, allele A*23:01, allele A*24:02, allele A*25:01, allele A*26:01, allele A*34:01, allele A*43:01, allele A*66:01, allele A*68:01 and allele A*69:01) VAR_082317
 14S -> L (in allele A*29:02, allele A*31:01, allele A*32:01, allele A*33:01 and allele A*74:01) VAR_082318
 23W -> R (in allele A*74:01) VAR_082319
 33F -> S (in allele A*23:01, allele A*24:02 and allele A*30:01; dbSNP:rs2075684) VAR_082320 dbSNP
 33F -> T (in allele A*29:02, allele A*31:01 and allele A*33:01; requires 2 nucleotide substitutions) VAR_082321
 33F -> Y (in allele A*02:05, allele A*11:01, allele A*25:01, allele A*26:01, allele A*34:01, allele A*43:01, allele A*66:01, allele A*68:01 and allele A*69:01; dbSNP:rs2075684) VAR_082322 dbSNP
 41R -> S (in allele A*30:01; dbSNP:rs1059423) VAR_082323 dbSNP
 55T -> S (in allele A*80:01) VAR_082324
 59R -> Q (in allele A*80:01) VAR_082325
 67Q -> R (in allele A*02:05; dbSNP:rs41559117) VAR_082326 dbSNP
 68R -> K (in alleles A*01:01 and allele A*36:01) VAR_082327
 80G -> E (in allele A*80:01) VAR_082328
 80G -> R (in allele A*30:01 and allele A*31:01; dbSNP:rs1059449) VAR_082329 dbSNP
 86Q -> E (in allele A*23:01, allele 24:02 and allele A*80:01) VAR_082330
 86Q -> G (in allele A*02:01 and allele A*02:05; requires 2 nucleotide substitutions) VAR_082331
 86Q -> L (in alleles A*29:02 and allele A*43:01) VAR_082332
 86Q -> R (in allele A*25:01, allele A*26:01, allele A*33:01, allele A*34:01, allele A*66:01, allele A*68:01 and allele A*69:01) VAR_082333
 87E -> N (in alleles A*25:01, allele A*26:01, allele A*33:01, allele A*34:01, allele A*66:01, allele A*68:01 and allele A*69:01; requires 2 nucleotide substitutions) VAR_082334
 87E -> Q (in allele A*29:02 and allele A*43:01) VAR_082335
 89R -> G (in allele A*23:01 and allele 24:02; dbSNP:rs199474430) VAR_082336 dbSNP
 90N -> K (in allele A*02:01, allele A*02:05, allele A*23:01, allele 24:02 and allele A*34:01; dbSNP:rs199474436) VAR_082337 dbSNP
 91V -> M (in allele A*01:01 and allele A*36:01) VAR_082338
 94Q -> H (in allele A*01:01, allele A*02:01, allele A*02:05, allele A*23:01, allele 24:02, allele A*25:01, allele A*26:01, allele A*31:01, allele A*32:01, allele A*33:01, allele A*36:01, allele A*43:01, allele A*74:01 and allele A*80:01; dbSNP:rs78306866) VAR_082339 dbSNP
 97T -> I (in allele A*31:01 and allele A*33:01; dbSNP:rs199474457) VAR_082340 dbSNP
 98D -> H (in allele A*02:01 and allele A*02:05) VAR_082341
 98D -> N (in allele A*80:01) VAR_082342
 100V -> A (in allele A*01:01, allele A*26:01, allele A*29:02, allele A*36:01, allele A*43:01 and allele A*80:01) VAR_082343
 100V -> E (in allele A*23:01, allele A*24:02, allele A*25:01 and allele A*32:01; dbSNP:rs1071742) VAR_082344 dbSNP
 101D -> N (allele A*01:01, allele A*23:01, allele A*24:02, allele A*26:01, allele A*29:02, allele A*36:01, allele A*43:01 and allele A*80:01; dbSNP:rs1136688) VAR_082345 dbSNP
 101D -> S (in allele A*25:01 and allele A*32:01; requires 2 nucleotide substitutions) VAR_082346
 114A -> D (in allele A*01:01, allele A*11:01, allele A*25:01, allele A*26:01, allele A*34:01, allele A*36:01, allele A*43:01, allele A*66:01 and allele A*80:01; dbSNP:rs1136692) VAR_082348 dbSNP
 119I -> L (in allele A*02:05, allele A*23:01 and allele 24:02; dbSNP:rs1071743) VAR_082349 dbSNP
 119I -> V (in allele A*02:01 and allele A*69:01) VAR_082350
 121I -> M (in allele A*23:01, allele 24:02, allele A*29:02, allele A*31:01, allele A*32:01, allele A*33:01, allele A*68:01 and allele A*74:01; dbSNP:rs1136695) VAR_082351 dbSNP
 121I -> R (in allele A*02:01, allele A*02:05, allele A*25:01, allele A*26:01, allele A*34:01, allele A*43:01, allele A*66:01 and allele A*69:01) VAR_082352
 123Y -> F (in allele A*23:01, allele 24:02; dbSNP:rs1136697) VAR_082353 dbSNP
 129S -> P (in allele A*01:01, allele A*11:01, allele A*25:01, allele A*26:01, allele A*32:01, allele A*34:01, allele A*36:01, allele A*43:01, allele A*66:01 and allele A*74:01; dbSNP:rs1136700) VAR_082354 dbSNP
 131G -> W (in allele A*02:01, allele A*02:05 and allele A*69:01; dbSNP:rs1136702) VAR_082355 dbSNP
 133F -> L (in allele A*32:01 and allele A*74:01; dbSNP:rs1059488) VAR_082356 dbSNP
 138R -> E (in allele A*30:01; requires 2 nucleotide substitutions) VAR_082357
 138R -> H (in allele A*02:01, allele A*02:05, allele A*23:01, allele A*24:02, allele A*69:01) VAR_082358
 138R -> Q (in allele A*25:01, allele A*26:01, allele A*31:01, allele A*32:01, allele A*33:01, allele A*34:01, allele A*43:01, allele A*66:01, allele A*74:01) VAR_082359
 140D -> H (in allele A*30:01) VAR_082360
 140D -> Y (in allele A*02:01, allele A*02:05, allele A*23:01, allele A*24:02 and allele A*69:01) VAR_082361
 151N -> K (in allele A*02:01, allele A*02:05, allele A*23:01, allele A*24:02, allele A*68:01 and allele A*69:01; dbSNP:rs1059509) VAR_082362 dbSNP
 166I -> T (in allele A*02:01, allele A*02:05, allele A*68:01 and allele A*69:01; dbSNP:rs1059516) VAR_082363 dbSNP
 168K -> Q (in allele A*23:01, allele A*25:01, allele A*26:01, allele A*29:02, allele A*30:01, allele A*31:01, allele A*32:01, allele A*33:01, allele A*34:01, allele A*43:01, allele A*66:01 and allele A*74:01) VAR_082364
 169R -> H (in allele A*02:01, allele A*02:05, allele A*68:01 and allele A*69:01; dbSNP:rs1059520) VAR_082365 dbSNP
 173A -> T (in allele A*25:01, allele A*26:01, allele A*34:01, allele A*43:01 and allele A*66:01; dbSNP:rs1059526) VAR_082366 dbSNP
 174A -> V (in allele A*01:01 and allele A*36:01) VAR_082367
 175H -> R (in allele A*23:01, allele A*29:02, allele A*30:01, allele A*31:01, allele A*32:01, allele A*33:01, allele A*74:01 and allele A*80:01) VAR_082368
 176E -> A (in allele A*01:01, allele A*11:01 and allele A*36:01) VAR_082369
 176E -> R (in allele A*80:01; requires 2 nucleotide substitutions) VAR_082370
 176E -> V (in allele A*02:01, allele A*02:05, allele A*23:01, allele A*24:02, allele A*29:02, allele A*31:01, allele A*32:01, allele A*33:01, allele A*68:01, allele A*69:01 and allele A*74:01; results in inefficient T cell recognition of epitopes derived from influenza A virus.; dbSNP:rs9256983) VAR_082371 dbSNP
 176E -> W (in allele A*30:01; requires 2 nucleotide substitutions) VAR_082372
 180L -> Q (in allele A*11:01 and allele A*24:02) VAR_082373
 180L -> R (in allele A*01:01 and allele A*36:01) VAR_082374
 180L -> W (in allele A*02:05, allele A*25:01, allele A*26:01, allele A*34:01, allele A*43:01, allele A*66:01, allele A*68:01; dbSNP:rs9260156) VAR_082375 dbSNP
 182A -> V (in allele A*01:01 and allele A*36:01) VAR_082376
 185D -> E (in allele A*01:01, allele A*02:01, allele A*02:05, allele A*11:01, allele A*23:01, allele A*24:02, allele A*25:01, allele A*26:01, allele A*29:02, allele A*30:01, allele A*31:01, allele A*32:01, allele A*33:01, allele A*34:01, allele A*36:01, allele A*43:01, allele A*66:01, allele A*68:01, allele A*69:01, allele A*74:01 and allele A*80:01; dbSNP:rs1059542) VAR_082377 dbSNP
 187T -> E (in allele A*80:01; requires 2 nucleotide substitutions) VAR_082378
 187T -> R (in allele A*01:01, allele A*11:01, allele A*25:01, allele A*26:01, allele A*43:01 and allele A*66:01) VAR_082379
 190E -> D (in allele A*01:01, allele A*23:01, allele A*24:02 and allele A*80:01; dbSNP:rs879577815) VAR_082380 dbSNP
 191W -> G (in allele A*01:01, allele A*23:01, allele A*24:02 and allele A*80:01; dbSNP:rs3098019) VAR_082381 dbSNP
 195Y -> H (in allele A*33:01) VAR_082382
 208P -> A (in allele A*02:01, allele A*02:05, allele A*25:01, allele A*26:01, allele A*29:02, allele A*32:01, allele A*34:01, allele A*43:01, allele A*66:01, allele A*68:01, allele A*69:01 and allele A*74:01) VAR_082383
 210K -> R (in allele A*33:01) VAR_082384
 217P -> A (in allele A*02:01, allele A*02:05, allele A*25:01, allele A*26:01, allele A*29:02, allele A*31:01, allele A*32:01, allele A*33:01, allele A*34:01, allele A*43:01, allele A*66:01, allele A*68:01, allele A*69:01, allele A*74:01) VAR_082385
 218I -> V (in allele A*02:01, allele A*02:05, allele A*25:01, allele A*26:01, allele A*29:02, allele A*31:01, allele A*32:01, allele A*33:01, allele A*34:01, allele A*43:01, allele A*66:01, allele A*68:01, allele A*69:01 and allele A*74:01) VAR_082386
 231G -> S (in allele A*02:01, allele A*02:05, allele A*25:01, allele A*26:01, allele A*29:02, allele A*31:01, allele A*32:01, allele A*33:01, allele A*34:01, allele A*43:01, allele A*66:01, allele A*68:01, allele A*69:01, allele A*74:01 and allele A*80:01) VAR_082387
 269A -> V (in allele A*68:01; impairs binding to CD8A and reduces recognition by antigen-specific CD8-positive T cells) VAR_082388
 270A -> S (in allele A*25:01, allele A*26:01, allele A*29:02, allele A*31:01, allele A*32:01, allele A*33:01, allele A*34:01, allele A*43:01, allele A*66:01 and allele A*74:01) VAR_082389
 277E -> K (in allele A*80:01) VAR_082390
 277E -> Q (in allele A*02:01, allele A*02:05, allele A*25:01, allele A*26:01, allele A*29:02, allele A*31:01, allele A*32:01, allele A*33:01, allele A*34:01, allele A*43:01, allele A*66:01, allele A*68:01, allele A*69:01 and allele A*74:01) VAR_082391
 279Q -> K (in allele A*80:01) VAR_082392
 292K -> E (in allele A*80:01) VAR_082393
 300L -> P (in allele A*02:01, allele A*02:05, allele A*23:01, allele A*24:02, allele A*25:01, allele A*26:01, allele A*29:02, allele A*31:01, allele A*32:01, allele A*33:01, allele A*34:01, allele A*43:01, allele A*66:01, allele A*68:01, allele A*69:01, allele A*74:01 and allele A*80:01) VAR_082394
 306I -> V (in allele A*23:01 and allele A*24:02) VAR_082395
 307P -> H (in allele A*23:01) VAR_082396
 312I -> L (in allele A*34:01) VAR_082397
 318L -> F (in allele A*02:01, allele A*02:05, allele A*25:01, allele A*26:01, allele A*29:02, allele A*31:01, allele A*32:01, allele A*33:01, allele A*34:01, allele A*43:01, allele A*66:01, allele A*68:01, allele A*69:01 and allele A*74:01) VAR_082398
 321V -> M (in allele A*32:01 and allele A*74:01) VAR_082399
 322I -> F (in allele A*29:02, allele A*31:01, allele A*32:01, allele A*33:01 and allele A*74:01) VAR_082400
 323T -> A (in allele A*25:01, allele A*26:01, allele A*29:02, allele A*31:01, allele A*32:01, allele A*33:01, allele A*34:01, allele A*43:01, allele A*66:01, allele A*74:01 and allele A*80:01) VAR_082401
 331M -> R (in allele A*29:02, allele A*31:01, allele A*32:01, allele A*33:01 and allele A*74:01) VAR_082402
 334R -> K (allele A*80:01) VAR_082403
 335K -> N (in allele A*23:01 and allele A*24:02) VAR_082404
 338D -> V (allele A*80:01) VAR_082405
 345T -> S (in allele A*02:01, allele A*02:05, allele A*23:01, allele A*24:02, allele A*25:01, allele A*26:01, allele A*29:02, allele A*31:01, allele A*32:01, allele A*33:01, allele A*34:01, allele A*43:01, allele A*66:01, allele A*68:01 allele A*69:01, allele A*74:01 and allele A*80:01) VAR_082406
 358V -> M (in allele A*25:01, allele A*26:01, allele A*29:02, allele A*31:01, allele A*32:01, allele A*33:01, allele A*34:01, allele A*43:01, allele A*66:01 and allele A*74:01) VAR_082407
 309-332Helical
 125-188
 227-283
 103-107GTLRG -> RIALR (in allele A*23:01, allele A*24:02, allele A*25:01 and allele A*32:01; Bw4 motif RIALR is involved in the recognition of NK cell inhibitory receptor KIR3DL1) VAR_082347
 25-203MHC class I-like antigen recognition-like
IPR011161PF00129
 219-290Immunoglobulin C1-set
IPR003597PF07654
 337-364MHC class I, alpha chain, C-terminal
IPR010579PF06623

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRange
Crystal structure of HLA-A3*01 in complex with a mutant beta-catenin peptide Heteromer
P35222; P61769;
MES; 10×SO4;PEG;6o9c25-302
Assess
Crystal structure of HLA-A3*01 in complex with a wild-type beta-catenin peptide Heteromer
P35222; P61769;
PG4;MES;IMD;PEG;EDO;6o9b25-301
Assess
HLA-A02 carrying YLGGPDFPTI Heteromer
P61769;
14×EDO;SO4;5c0g25-299
Assess
HLA-A02 carrying MVWGPDPLYV Heteromer
P61769;
10×EDO;GOL;5n1y25-299
Assess
A structural basis for immunodominant human T-cell receptor recognition. Heteromer
P01848; P01850; P61769;
1oga25-299
Assess
CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4-PEPTIDE COMPLEX Heteromer
P43358; P61769;
1PG;1i4f25-299
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCMV pp65-495-503 nonapeptide A7H v… Heteromer
P61769; Q6SW59;
3mrb25-299
Assess
Crystal structure of HLA-A*1101 with sars nucleocapsid peptide Heteromer
P59595; P61769;
SO4;GOL;1x7q25-299
Assess
HLA-A02 carrying RQWGPDPAAV Heteromer
P61769;
18×EDO;GOL;MES;SO4;ACY;5c0f25-299
Assess
HLA-A02 carrying YLGGPDFPTI Heteromer
P61769;
BR; 17×EDO;GOL; 11×PG4;5c0e25-299
Assess
Engineered Human HLA_A2 MHC Class I molecule in complex with NV9 peptide Heteromer
P61769;
GOL;CO;6q3k24-298
Assess
HAL-A02 carrying RQFGPDFPTI Heteromer
P61769;
10×EDO;GOL;SO4;CA;5c0i25-299
Assess
HLA Class I antigen Heteromer
P40967; P61769;
18×EDO; 10×GOL;SO4;5eu525-299
Assess
Human Class I MHC HLA-A2 in complex with the nonameric Melan-A/MART-1(27-35) peptide having A27L su… Heteromer
P61769; Q16655;
GOL;FMT;NA;2gtw25-299
Assess
HLA A02 presenting SLYNTIATL Heteromer
P04591; P61769;
EDO;GOL;5nmh25-299
Assess
The Structural Dynamics and Energetics of an Immunodominant T-cell Receptor are Programmed by its V… Heteromer
P03485; P61769;
2vll25-299
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with Human Prostaglandin Transporter dec… Heteromer
P61769; Q92959;
3mrr25-299
Assess
T cell cross-reactivity and conformational changes during TCR engagement. Heteromer
P61769;
2v2x25-299
Assess
Human Class I MHC HLA-A2 in complex with the HuD (G2L) peptide variant Heteromer
P61769;
GOL;3pwn25-299
Assess
T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT Heteromer
P61769;
2v2w25-299
Assess
Crystal Structure of HLA-A68 presenting a C-terminally extended peptide Heteromer
P30279; P61769;
EDO;NI;CD;CO;6ei225-299
Assess
HLA-A2.1 KVAEIVHFL Heteromer
E0YFW1; P61769;
3v5h25-299
Assess
HLA-A02 carrying RQFGPDWIVA Heteromer
P61769;
11×EDO;SO4;CA;GOL;5c0j25-299
Assess
Structure of HLA-A2 in complex with an altered peptide ligands based on Mart-1 variant epitope Heteromer
P61769; Q16655;
GOL;4wj525-299
Assess
Ca2+ release from the endoplasmic reticulum of NY-ESO-1 specific T cells is modulated by the affini… Heteromer
P61769; P78358;
3kla25-299
Assess
Human Class I MHC HLA-A2 in complex with the HuD peptide Heteromer
P61769;
GOL;3pwl25-299
Assess
Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… Heteromer
P35222; P61769;
CD;MG;GOL;3fqn25-299
Assess
HLA A02 presenting SLFNTIAVL Heteromer
P04591; P61769;
EDO;GOL;SO4;5nmk25-299
Assess
Human HLA-A*0201-ALWGPDPAAA Heteromer
P01308; P61769;
3utq25-299
Assess
Human Class I MHC HLA-A2 in complex with Mart-1(27-35) nonameric peptide Heteromer
P61769; Q16655;
GOL;NA;3qfd25-299
Assess
HLA-A02 carrying AQWGPDPAAA Heteromer
P01308; P61769;
5c0d25-299
Assess
Human Class I MHC HLA-A2 in complex with the HuD (G2L,I9V) peptide variant Heteromer
P61769;
GOL;3pwj25-299
Assess
Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… Heteromer
P61769; Q9Y4H2;
CD;MG;GOL;3fqx25-299
Assess
TCR F50 recgonizing M1-HLA-A2 Heteromer
P03485; P61769;
5tez25-299
Assess
Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… Heteromer
P35222; P61769;
GOL;MG;CD;3fqr25-299
Assess
Structure of HLA-A2 P130 Heteromer
P61769; Q76R61;
SO4;5e0025-299
Assess
Human Class I MHC HLA-A2 in complex with the nonameric Melan-A/MART-1(27-35) peptide having A28L su… Heteromer
P61769; Q16655;
GOL;NA;2gtz25-299
Assess
Human Class I MHC HLA-A2 in complex with the modified HTLV-1 TAX (Y5K-4-[3-Indolyl]-butyric acid) p… Heteromer
P61769;
GOL;NA;FMT;2git25-299
Assess
Human Class I MHC HLA-A2 in complex with the Peptidomimetic ELA-2 Heteromer
P61769;
GOL;3o3d25-299
Assess
Structural and kinetic basis for heightened immunogenicity of T cell vaccines Heteromer
A0A0B4J279; A0A0K0K1A5; P01848; P01850; P61769; P78358;
2bnq25-299
Assess
Crystal Structure of RTY Phosphopeptide Bound to Human Class I MHC HLA-A2 Heteromer
P61769; Q8WVV4;
NA;EDO;3bh925-299
Assess
Human Leukocyte Antigen Class I A02 Carrying LLWNPGMAV Heteromer
P03314; P61769;
EDO;EPE;PEG;SO4;5n6b25-299
Assess
Human Class I MHC HLA-A2 in complex with the decameric Melan-A/MART-1(26-35) peptide Heteromer
P61769; Q16655;
GOL;NA;2gt925-299
Assess
Peptide length determines the outcome of T cell receptor/peptide-MHCI engagement Heteromer
P61769;
18×EDO;GOL;SO4;4i4w25-299
Assess
Human Leukocyte Antigen presenting ILGKFLHRL Heteromer
O14746; P61769;
15×EDO;GOL;SO4;5meo25-299
Assess
Crystal Structure of ILNAMIVKI peptide bound to HLA-A2 Heteromer
P61769;
ACT;GOL;MG;6opd25-299
Assess
Crystal structure of Melanoma Antigen gp100(209-217) Bound to Human Class I MHC HLA-A2 Heteromer
P40967; P61769;
GOL;1tvb25-299
Assess
Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… Heteromer
P30305; P61769;
CD;MG;GOL;3fqt25-299
Assess
CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-6V Heteromer
P61769;
1i7u25-299
Assess
HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) IN COMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV… Heteromer
P61769;
1duz25-299
Assess
Human Class I MHC HLA-A2 in complex with the Peptidomimetic ELA-1 Heteromer
P61769;
GOL;3o3a25-299
Assess
Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… Heteromer
P30305; P61769;
GOL;CD;MG;3fqu25-299
Assess
Crystal Structure of a citrulline peptide variant of the minor histocompatibility peptide HA-1 in c… Heteromer
P61769;
3ft225-299
Assess
Crystal structure of the binary complex between HLA-A2 and HCMV NLV-M5T peptide variant Heteromer
P61769;
3gsu25-299
Assess
Crystal structure of Modified Melanoma Antigen gp100(209-T2M) Bound to Human Class I MHC HLA-A2 Heteromer
P40967; P61769;
13×GOL;1tvh25-299
Assess
Human Class I MHC HLA-A2 in complex with the Peptidomimetic ELA-2.1 Heteromer
P61769;
GOL;3o3e25-299
Assess
Crystal structure of HLA-A2*0201 in complex with a decameric altered peptide ligand from the MART-1… Heteromer
P61769;
ZN;1jf125-299
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide V5M v… Heteromer
P61769; Q03463;
3mrj25-299
Assess
Human Leukocyte Antigen A02 presenting ILAKFLHEL Heteromer
O14746; P61769;
10×EDO;CA;MES;SO4;GOL;5mer25-299
Assess
Human Class I MHC HLA-A2 in complex with the Tel1p peptide Heteromer
P38110; P61769;
GOL;3h7b25-299
Assess
Crystal Structures of High Affinity Human T-Cell Receptors Bound to pMHC Reveal Native Diagonal Bin… Heteromer
P01848; P61769; P78358;
GOL;MG;SO4;IPA;EPE;2p5e25-299
Assess
Human Class I MHC HLA-A2 in complex with the WT-1 (126-134) (R1Y) peptide variant. Heteromer
P19544; P61769;
GOL;3myj25-299
Assess
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
P61769;
1t1z25-299
Assess
Crystal Structure of the minor histocompatibility peptide HA-1Arg in complex with HLA-A2 Heteromer
P61769;
3ft425-299
Assess
Crystal structure of an lmp2a-derived peptide bound to human class i mhc hla-a2 Heteromer
P13285; P61769;
IOD;EDO;CL;3rew25-299
Assess
Human Class I MHC HLA-A2 in complex with the native nonameric Melan-A/MART-1(27-35) peptide Heteromer
P61769; Q16655;
GOL;2guo25-299
Assess
Human Class I MHC HLA-A2 in complex with the Peptidomimetic ELA-1.1 Heteromer
P61769;
GOL;3o3b25-299
Assess
Crystal structure of the binary complex between HLA-A2 and HCMV NLV-M5Q peptide variant Heteromer
P61769;
3gsv25-299
Assess
Structural and kinetic basis for heightened immunogenicity of T cell vaccines Heteromer
A0A0B4J279; A0A0K0K1A5; P01848; P01850; P61769; P78358;
2bnr25-299
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to a photocleavable peptide Heteromer
P61769;
MES;2x4q25-299
Assess
A2 HLA complex with L8A heteroclitic variant of Melanoma peptide Heteromer
P61769;
11×GOL;MES;4jfq25-299
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1406-1415 decapeptide Heteromer
P61769; Q9DIT6;
3mrm25-299
Assess
Rational development of high-affinity T-cell receptor-like antibodies Heteromer
P61769; P78358;
3gjf25-299
Assess
Crystal Structure of ILNAMITKI peptide bound to HLA-A2 Heteromer
P61769; Q68CZ6;
GOL;NA;6pte25-299
Assess
A2 HLA complex with G4A heteroclitic variant of Melanoma peptide Heteromer
P61769;
GOL;EDO;SO4;4jfp25-299
Assess
Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… Heteromer
P61769; Q9Y4H2;
CD;CO;3fqw25-299
Assess
Crystal Structure of the minor histocompatibility peptide HA-1His in complex with HLA-A2 Heteromer
P61769; Q92619;
3ft325-299
Assess
Crystal structure of a complex between the human adenovirus type 2 E3-19K protein and MHC class I m… Heteromer
P0C213; P61769; P68979;
4e5x25-299
Assess
Crystal structure of HTLV-1 TAX peptide Bound to Human Class I MHC HLA-A2 with the E63Q and K66A mu… Heteromer
P14079; P61769;
13×GOL;SCN;2av125-299
Assess
HLA Class I antigen Heteromer
P40967; P61769;
EDO;GOL;5eu325-299
Assess
1E6 TCR in complex with HLA-A02 carrying RQFGPDWIVA Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P61769;
15×EDO;PG4;SO4;GOL;5c0c25-299
Assess
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
P61769;
1t1y25-299
Assess
Xenoreactive complex AHIII 12.2 TCR bound to p1049/HLA-A2.1 Heteromer
P01849; P04213; P61769; Q9NPA0;
1lp925-299
Assess
THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE Heteromer
P27797; P61769;
2clr25-299
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to a photocleavable peptide Heteromer
P61769;
GOL;MES;2x7025-299
Assess
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance Heteromer
P61769; Q9YYH6;
3giv25-299
Assess
HLA-A2.1 KVAELVHFL Heteromer
E0YFW1; P61769;
3v5d25-299
Assess
Human Class I MHC HLA-A2 in complex with the WT-1 (126-134) peptide Heteromer
P19544; P61769;
GOL;3hpj25-299
Assess
Structure of HLA-A2 P130 Heteromer
P61769;
PEG;5wsh25-299
Assess
Human Class I MHC HLA-A2(A150P) in complex with the Tel1p peptide Heteromer
P38110; P61769;
GOL;3h9h25-299
Assess
Crystal Structure of HLA-A*0201 in complex with NA231, an influenza epitope Heteromer
P61769; Q9Q0U7;
5swq25-299
Assess
HLA Class I antigen Heteromer
A0A0B4J279; A0A592; A0A5B9; P01848; P40967; P61769;
10×EDO;GOL;SO4;5eu625-299
Assess
1E6 TCR in complex with HLA-A02 carrying RQFGPDFPTI Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P61769;
30×EDO;GOL;SO4;5c0b25-299
Assess
A T cell receptor in complex with HLA-A0201 restricted Hepatitis C virus NS3 peptide (KLVALGINAV) Heteromer
P27958; P61769;
5yxn25-299
Assess
Crystal structure of HTLV-1 TAX peptide Bound to Human Class I MHC HLA-A2 with the K66A mutation in… Heteromer
P14079; P61769;
14×GOL;2av725-299
Assess
Crystal structure of LS01-TCR/M1-HLA-A*02 complex Heteromer
P03485; P61769;
GOL;5isz25-299
Assess
Crystal structure of HLA-A0201 in complex with an azobenzene- containing peptide Heteromer
P61769;
IPA;4uq325-299
Assess
Directed Evolution of Human T-cell Receptor CDR2 residues by phage display dramatically enhances af… Heteromer
P01848; P61769; P78358;
NA;GOL;2f5325-299
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to HIV-1 Peptide RT468-476 Heteromer
P03366; P61769;
MES;GOL;2x4u25-299
Assess
Human Class I MHC HLA-A2(A150P) in complex with the Tax peptide Heteromer
P61769;
GOL;3ixa25-299
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant Heteromer
P61769; Q16655;
3mrp25-299
Assess
Crystal structure of non-phosphorylated form of AMPD2 phosphopeptide bound to HLA-A2 Heteromer
P61769; Q01433;
EDO;NA;4no525-299
Assess
A2 HLA complex with E1A heteroclitic variant of Melanoma peptide Heteromer
P61769;
GOL;SO4;4jfo25-299
Assess
1E6 TCR in complex with HLA-A02 carrying YQFGPDFPIA Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P61769;
SO4;EDO;5c0725-299
Assess
Human Leukocyte Antigen Class I A02 Carrying LLWNGPMQV Heteromer
P03314; P61769;
EDO;GOL;PEG;6ssa25-299
Assess
HLA Class I antigen Heteromer
P40967; P61769;
GOL;EDO;SO4;5eu425-299
Assess
Crystal Structure of ILNAMIAKI peptide bound to HLA-A2 Heteromer
P61769; Q68CZ6;
GOL;6ptb25-299
Assess
Crystal structure of HLA-A2*0201 in complex with a nonameric altered peptide ligand (ALGIGILTV) fro… Heteromer
P61769;
1jht25-299
Assess
CRYSTAL STRUCTURE OF HLA-A*0201/OCTAMERIC TAX PEPTIDE COMPLEX Heteromer
P61769;
1duy25-299
Assess
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
P61769;
1t2125-299
Assess
Crystal structure of a H5-specific CTL epitope variant derived from H5N1 influenza virus in complex… Heteromer
P61769; Q1WDM0;
3mgt25-299
Assess
Crystal structures of high affinity human T-cell receptors bound to pMHC reveal native diagonal bin… Heteromer
P01848; P61769; P78358;
SO4; 11×GOL;CA;MG;EPE;2p5w25-299
Assess
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
O11818; P61769;
1s8d25-299
Assess
CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VA… Heteromer
P61769;
1i1y25-299
Assess
HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOM… Heteromer
P43357; P61769;
1qew25-299
Assess
CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058 Heteromer
P61769;
1i7r25-299
Assess
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
P61769;
1t1x25-299
Assess
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
P61769;
1t2025-299
Assess
Crystal Structure of the human cytomegalovirus protein US2 bound to the MHC class I molecule HLA-A2… Heteromer
P09713; P14079; P61769;
1im325-299
Assess
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
P61769;
1t2225-299
Assess
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
O11822; P61769;
1t1w25-299
Assess
Newly identified epitope Mn2 from SARS-CoV M protein complexed withHLA-A*0201 Heteromer
P59596; P61769;
3i6g25-299
Assess
STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY … Heteromer
P04602; P61769;
1qvo25-299
Assess
Human Leukocyte Antigen Class I A02 Carrying LLWNGPIAV Heteromer
P03314; P61769;
GOL;EDO;SO4;PEG;6ss825-299
Assess
Crystal Structure Determination Of HLA A2 Complexed to Peptide GP2 with the substitution (I2L/V5L/L… Heteromer
P61769;
1eey25-299
Assess
Human Leukocyte Antigen A02 presenting ILAKFLHTL Heteromer
O14746; P61769;
SO4;EDO;5meq25-299
Assess
The complex between TCR A6 and human Class I MHC HLA-A2 with the modified TAX (Y5F) peptide Heteromer
P61769;
11×GOL;3qfj25-299
Assess
Crystal structure of a H5-specific CTL epitope derived from H5N1 influenza virus in complex with HL… Heteromer
P61769; Q2F4V2;
3mgo25-299
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to Cytomegalovirus (CMV) pp65 epitope Heteromer
P06725; P61769;
GOL;2x4r25-299
Assess
Crystal structure of non-phosphorylated form of RTF PHOSPHOPEPTIDE BOUND TO HLA-A2 in complex with … Heteromer
O15061; P61769; Q8NHL6;
6ewo25-299
Assess
The complex between TCR DMF5 and human Class I MHC HLA-A2 with the bound MART-1(27-35) nonameric pe… Heteromer
P01848; P61769;
3qdj25-299
Assess
Crystal Structure Determination of HLA-A2.1 Complexed to GP2 Peptide Variant(I2L/V5L) Heteromer
P61769;
1eez25-299
Assess
The Structural Dynamics and Energetics of an Immunodominant T-cell Receptor are Programmed by its V… Heteromer
P03485; P61769;
2vlr25-299
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to a photocleavable peptide Heteromer
P61769;
GOL;MES;2x4p25-299
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to a Peiodate- cleavable peptide Heteromer
P06725; P61769;
GOL;MES;2x4t25-299
Assess
Crystal Structures of High Affinity Human T-Cell Receptors Bound to pMHC RevealNative Diagonal Bind… Heteromer
P01848; P61769; P78358;
SO4;PGE;7PE; 11×GOL;2pye25-299
Assess
NYBR1-A2-SLSKILDTV Heteromer
P61769; Q9BXX3;
PEG;EDO;GOL;SO4;EPE;6r2l25-299
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to HIV-1 envelope peptide env120-128 Heteromer
P04583; P61769;
MES;GOL;2x4o25-299
Assess
HLA2.1 KVAELVWFL Heteromer
E0YFW1; P61769;
3v5k25-299
Assess
1E6 TCR in Complex with HLA-A0e carrying RQWGPDPAAV Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P61769;
12×EDO;GOL;SO4;5c0825-299
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to residual fragments of a photocleavable peptide t… Heteromer
P61769;
GOL;2x4n25-299
Assess
A2-MHC Complex carrying FLTGIGIITV Heteromer
P61769;
EDO;SO4;GOL;4gks25-299
Assess
The complex between high-affinity TCR DMF5(alpha-D26Y,beta-L98W) and human Class I MHC HLA-A2 with … Heteromer
P61769; Q16655;
6d7825-299
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant Heteromer
P61769; Q16655;
3mro25-299
Assess
Conflicting selective forces affect CD8 T-cell receptor contact sites in an HLA-A2 immunodominant H… Heteromer
O11822; P61769;
2c7u25-299
Assess
Crystal structure of HLA-A2 in complex with LILRB1 Heteromer
P04585; P61769; Q8NHL6;
6ewa25-299
Assess
Crystal structure of DMF5 TCR bound to HLA-A2 presenting synthetic peptide SMLGIGIVPV Heteromer
P61769;
6am525-299
Assess
POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTE… Heteromer
P04626; P61769;
1qr125-299
Assess
Large CDR3a loop alteration as a function of MHC mutation Heteromer
P04213; P61769; Q9NPA0;
2uwe25-299
Assess
The Structural Dynamics and Energetics of an Immunodominant T-cell Receptor are Programmed by its V… Heteromer
P61769;
2vlj25-299
Assess
Structures of HLA-A*1101 in complex with immunodominant nonamer and decamer HIV-1 epitopes clearly … Heteromer
P12499; P61769;
1q9425-299
Assess
Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a mela… Heteromer
P01848; P01850; P61769; Q16655;
EPE;SO4;4jff25-299
Assess
Crystal structure of HLA-A1101 in complex with an azobenzene- containing peptide Heteromer
P61769;
4uq225-299
Assess
MHC A02 Allele presenting MTSAIGILVP Heteromer
P61769;
6g3j25-299
Assess
1E6 TCR in complex with HLA-A02 carrying MVW peptide Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P61769;
EDO;SO4;GOL;5c0a25-299
Assess
Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a mela… Heteromer
P01848; P01850; P61769;
TAM; 11×SO4;4jfd25-299
Assess
Crystal structure of LS10-TCR/M1-HLA-A*02 complex Heteromer
P03485; P61769;
EDT;5jhd25-299
Assess
HLA class I histocompatibility antigen Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P61769;
SO4;5c0925-299
Assess
THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEP… Heteromer
P14079; P61769;
1hhk25-299
Assess
The Structural Dynamics and Energetics of an Immunodominant T-cell Receptor are Programmed by its V… Heteromer
P61769;
2vlk25-299
Assess
THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEP… Heteromer
P04588; P61769;
1hhj25-299
Assess
AH3 recognition of mutant HLA-A2 W167A Heteromer
P01849; P61769; Q9NPA0;
2jcc25-299
Assess
Crystal structure of the T-cell receptor NYE_S1 bound to HLA A2*01-SLLMWITQV Heteromer
P61769; P78358;
6rpb25-299
Assess
THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEP… Heteromer
P03485; P61769;
1hhi25-299
Assess
CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2-MICROGLOBULIN/PEPTIDE P1049 COMPLEX Heteromer
P61769; Q9NPA0;
1b0g25-299
Assess
COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201 Heteromer
A0A0K0K1A5; A0A5B9; P01848; P04437; P14079; P61769;
1bd225-299
Assess
Human Leukocyte Antigen Class I A02 Carrying LLWAGPMAV Heteromer
P03314; P61769;
NA;EDO;SO4;GOL;6ss725-299
Assess
RD-1 Mart-1 High bound to Mart-1 decameric peptide (ELA) in complex with HLA-A2 Heteromer
P61769; Q16655;
5e9d25-299
Assess
Crystal structure of MHC CLass I HLA-A2.1 bound to a peptide representing the epitope of the H5N1 (… Heteromer
P61769; Q33CG5;
GOL;MES;2x4s25-299
Assess
The complex between high affinity TCR DMF5(alpha-D26Y,beta-L98W) and human Class I MHC HLA-A2 with … Heteromer
P61769; Q16655;
4l3e25-299
Assess
The complex between TCR A6 and human Class I MHC HLA-A2 with the modified HTLV-1 TAX (Y5K-4-[3-Indo… Heteromer
P01848; P01850; P61769;
SO4; 13×GOL;3IB;2gj625-299
Assess
Crystal structure of the T-cell receptor NYE_S2 bound to HLA A2*01-SLLMWITQV Heteromer
P61769; P78358;
6rpa25-299
Assess
The complex between TCR DMF4 and human Class I MHC HLA-A2 with the bound MART-1(27-35) nonameric pe… Heteromer
P01848; P61769; Q16655;
3qeq25-299
Assess
1E6-A*0201-ALWGPDPAAA Complex, Triclinic Heteromer
P01308; P61769;
3utt25-299
Assess
THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEP… Heteromer
P04582; P61769;
1hhg25-299
Assess
Structure of HLA-A2 in complex with D76N b2m mutant and NY-ESO1 double mutant Heteromer
P61769;
CL;GOL;4l3c25-299
Assess
COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND THE T CELL CORECEPTOR CD8 Heteromer
P01732; P61769;
1akj25-299
Assess
The complex between TCR A6 and human Class I MHC HLA-A2 with the bound HuD peptide Heteromer
P01848; P61769;
GOL;SO4;3pwp25-299
Assess
The complex between TCR DMF5 and human Class I MHC HLA-A2 with the bound MART-1(26-35)(A27L) peptide Heteromer
P01848; P61769;
3qdg25-299
Assess
Crystal structure of non-phosphorylated form of RQA_V phosphopeptide bound to HLA-A2 in complex wit… Heteromer
P33241; P61769; Q8NHL6;
EDO;4no025-299
Assess
The complex between TCR A6 and human Class I MHC HLA-A2 with the bound Tel1p peptide Heteromer
P38110; P61769;
GOL;3h9s25-299
Assess
an affinity enhanced T cell receptor in complex with HLA-A0201 restricted HCV NS3 peptide KLVALGINAV Heteromer
P27958; P61769;
5yxu25-299
Assess
Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a mela… Heteromer
P01848; P01850; P61769;
SO4;GOL;4jfe25-299
Assess
Human Leukocyte Antigen Class I A02 Carrying LLWNGPMHV Heteromer
P03314; P61769;
PEG;SO4;GOL;6ss925-299
Assess
Human Leukocyte Antigen A02 presenting ILGKFLHWL Heteromer
O14746; P61769;
EDO;SO4;5mep25-299
Assess
1E6-A*0201-ALWGPDPAAA Complex, Monoclinic Heteromer
P01308; P61769;
SO4;3uts25-299
Assess
The complex between the high affinity version of A6 TCR (A6c134) and human Class I MHC HLA-A2 with … Heteromer
P0C213; P61769;
10×GOL;4ftv25-299
Assess
TCR-peptide specificity overrides affinity enhancing TCR-MHC interactions Heteromer
H2RG00; K7N5N2; O14746; P01850; P61769;
GOL;EDO;4mnq25-299
Assess
Structure of 5F3 TCR in complex with HLA-A2/MART-1 Heteromer
P61769; Q6PJ56;
NAG;6d7g25-299
Assess
868 TCR in complex with HLA A02 presenting SLYFNTIAVL Heteromer
P04591; P61769;
13×EDO;GOL;SO4;5nmg25-299
Assess
A2-MHC Complex carrying FATGIGIITV Heteromer
P61769;
SO4;4gkn25-299
Assess
The complex between TCR DMF4 and human Class I MHC HLA-A2 with the bound MART-1(26-35)(A27L) decame… Heteromer
P01848; P61769; Q16655;
3qdm25-299
Assess
Crystal structure of human class i mhc (hla-a2.1) complexed with beta 2-microglobulin and hiv-rt va… Heteromer
P61769;
1i1f25-299
Assess
The complex between TCR A6 and human Class I MHC HLA-A2 with the modified HTLV-1 TAX (Y5(3,4-difluo… Heteromer
P01850; P61769;
GOL;3d3v25-299
Assess
Newly identified epitope from SARS-CoV membrane protein complexed with HLA-A*0201 Heteromer
P59596; P61769;
3i6k25-299
Assess
CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V Heteromer
P61769;
1i7t25-299
Assess
Crystal Structure of HLA-A*2402 Complexed with a telomerase peptide Heteromer
O14746; P61769;
SO4;GOL;2bck25-299
Assess
Human Leukocyte Antigen A02 presenting ILAKFLHWL, in complex with cognate T-Cell Receptor Heteromer
O14746; P61769;
EDO;GOL;SO4;5men25-299
Assess
HLA class I histocompatibility antigen Heteromer
P61769;
EPE;SO4;EDO;6eqb25-299
Assess
The complex between TCR A6 and human Class I MHC HLA-A2 with the modified HTLV-1 TAX (Y5(4-fluoroPh… Heteromer
P01848; P01850; P61769;
GOL;3d3925-299
Assess
Large CDR3a loop alteration as a function of MHC mutation. Heteromer
P01849; P04213; P61769; Q9NPA0;
2j8u25-299
Assess
868 TCR in complex with HLA A02 presenting SLYNTIATL Heteromer
P04591; P61769;
EDO;GOL;SO4;5nmf25-299
Assess
CRYSTAL STRUCTURE OF HLA-A*0201 COMPLEXED WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL GROUP SUBSTITUT… Heteromer
P61769;
1b0r25-299
Assess
Rational development of high-affinity T-cell receptor-like antibodies Heteromer
P61769; P78358;
3hae25-299
Assess
MHC A02 Allele presenting MTSAIGILPV Heteromer
P61769;
6g3k25-299
Assess
868 TCR in complex with HLA A02 presenting SLYNTVATL Heteromer
P04591; P61769;
EDO;SO4;5nme25-299
Assess
Crystal Structure of the JM22 TCR in complex with HLA-A*0201 in complex with M1-G4E Heteromer
A0A075B6N1; A0A087WT01; A0A5B9; P01848; P61769;
5hho25-299
Assess
The complex between TCR a7b2 and human Class I MHC HLA-A0201-WT1 with the bound RMFPNAPYL peptide. Heteromer
P19544; P61769;
EDO;6rsy25-299
Assess
The complex among DMF5(alpha-D26Y, alpha-Y50A,beta-L98W) TCR, human Class I MHC HLA-A2 and MART-1(2… Heteromer
P61769; Q16655;
6dkp25-299
Assess
THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEP… Heteromer
P12901; P61769;
1hhh25-299
Assess
Structural basis for ineffective T-cell responses to MHC anchor residue improved heteroclitic pepti… Heteromer
P61769; Q16655;
EDO;4qok25-299
Assess
Structure of ESK1 in complex with HLA-A*0201/WT1 Heteromer
P19544; P61769;
4wuu25-299
Assess
1E6 TCR in Complex with HLA-A02 carrying AQWGPDPAAA Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01308; P01848; P61769;
5hyj25-299
Assess
Structure of wtMHC class I with NY-ESO1 double mutant Heteromer
P61769;
CL;GOL;4l2925-299
Assess
Crystal structure of the T-cell receptor NYE_S3 bound to HLA A2*01-SLLMWITQV Heteromer
P61769; P78358;
6rp925-299
Assess
HLA class I histocompatibility antigen Heteromer
P61769;
SO4;6eqa25-299
Assess
Crystal structure of non-phosphorylated form of RLS PHOSPHOPEPTIDE BOUND TO HLA-A2 in complex with … Heteromer
P61769; Q8NC44; Q8NHL6;
6ewc25-299
Assess
human 199.54-16 TCR in complex with Melan-A/MART-1 (26-35) peptide and HLA-A2 Heteromer
P61769; Q16655;
SCN;K;CL;5nht25-299
Assess
human 199.16 TCR in complex with Melan-A/MART-1 (26-35) peptide and HLA-A2 Heteromer
A0A075B6N1; P01848; P61769; Q16655;
NA;5nqk25-299
Assess
HLA-A2 (A*02:01) bound to a peptide from the Epstein-Barr virus BRLF1 protein Heteromer
P61769; Q3KSS7;
6nca25-299
Assess
Crystal Structure of HLA-A2 Bound to LIR-1, a Host and Viral MHC Receptor Heteromer
P12499; P61769; Q8NHL6;
1p7q25-299
Assess
Crystal structure of HA-1 minor histocompatibility antigen bound to human class I MHC HLA-A2 Heteromer
P61769; Q92619;
3d2525-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide Heteromer
P61769; Q03463;
CIT;3mrg25-298
Assess
Crystal structure of BRLF peptide from EBV in complex with HLA-A1101. Heteromer
P61769;
GOL;6joz25-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with AFP137 nonapeptide Heteromer
P02771; P61769;
3mrk25-298
Assess
The structure of HLA-A*3003/NP44 Heteromer
P61769; Q9Q0U8;
6j2a25-298
Assess
Crystal Structure of HLA-A*0201 in complex with FLNDK, a 15 mer self-peptide Heteromer
P61769;
PEG;CL;4u6y25-298
Assess
Structure of HLA-A2:01 with the 12-mer peptide F12K Heteromer
B6KDY1; P61769;
GOL;5ddh25-298
Assess
The structure of HLA-A*3001/RT313 Heteromer
P04585; P61769;
6j1w25-298
Assess
Crystal structure of the binary complex between HLA-A2 and HCMV NLV peptide Heteromer
P06725; P61769;
3gso25-298
Assess
Crystal Structure of PKD2 Phosphopeptide Bound to Human Class I MHC HLA-A2 Heteromer
P61769; Q9BZL6;
EDO;3bgm25-298
Assess
HLA-A*1101 in complex with HBV peptide homologue Heteromer
P61769;
SO4;2hn725-298
Assess
The structure of HLA-A*3003/MTB Heteromer
P61769; P9WNK3;
6j2925-298
Assess
Crystal Structure of RQA_M Phosphopeptide Bound to HUMAN Class I MHC HLA-A2 Heteromer
P33241; P61769;
EDO;3bh825-298
Assess
Crystal structure of peptide in complex with HLA-A1101. Heteromer
P61769;
GOL;6jp325-298
Assess
HLA-A24 in complex with HIV-1 Nef126-10(8I10F) Heteromer
P04603; P61769;
3wl925-298
Assess
Crystal Structure of HLA-A*0201 in complex with ALQDA, a 15 mer self-peptide Heteromer
P61769;
CL;PEG;MG;4u6x25-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCMV pp65-495-503 nonapeptide V6G v… Heteromer
P06725; P61769;
3mrd25-298
Assess
Crystal Structure of HLA-A*2402 Complexed with a Newly Identified Peptide from 2009 H1N1 PB1 (498-5… Heteromer
P61769; Q9YXL6;
4f7t25-298
Assess
Crystal structure of AMPD2 phosphopeptide bound to HLA-A2 Heteromer
P61769; Q01433;
EDO;4no325-298
Assess
Crystal structure of 10-mer peptide from EBV in complex with HLA-A1101. Heteromer
P13285; P61769;
GOL;5grd25-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCMV pp65-495-503 nonapeptide V6C v… Heteromer
P06725; P61769;
3mrc25-298
Assess
The High Resolution Crystal Structure of HLA-A1 Complexed with the MAGE-A1 Peptide Heteromer
P43355; P61769;
GOL;3bo825-298
Assess
The complex between H27-14 TCR and HLA-A24 bound to HIV-1 Nef134-10(6L) peptide Heteromer
P61769; Q9WPU2;
3vxs25-298
Assess
Structure of HLA-A68 complexed with a tumor antigen derived peptide Heteromer
P40126; P61769;
GOL;4hx125-298
Assess
Crystal structure of the binary complex between HLA-A2 and HCMV NLV-T8A peptide variant Heteromer
P61769;
3gsw25-298
Assess
Structure of HLA-A2:01 with peptide G9L Heteromer
P61769;
GOL;5enw25-298
Assess
Structure of HLA-A2:01 with the 11-mer peptide F11V Heteromer
P61769; S7UWA0;
GOL;5d9s25-298
Assess
Crystal Structure of HLA-A*68:01 in complex with NP145-156, a 12 mer influenza peptide Heteromer
P61769; Q9Q0U8;
IOD;MG;SO4;6pbh25-298
Assess
Crystal Structure of HLA-A*2402 Complexed with a Newly Identified Peptide from 2009H1N1 PB1 (496-50… Heteromer
P61769; Q9YXL6;
4f7p25-298
Assess
Crystal Structure of HLA-A*0201 in complex with M1-G4E Heteromer
P61769;
5hhp25-298
Assess
Crystal structure of non-phosphorylated form of PKD2 phosphopeptide bound to HLA-A2 Heteromer
P61769; Q9BZL6;
CD;GOL;4nny25-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCMV pp65-495-503 nonapeptide M5A v… Heteromer
P61769; Q6SW59;
3mr925-298
Assess
Crystal structure of dual peptide from EBV in complex with HLA-A*11:01 Heteromer
P13285; P61769;
GOL;5grg25-298
Assess
Crystal structure of the binary complex between HLA-A2 and HCMV NLV-M5V peptide variant Heteromer
P61769;
3gsr25-298
Assess
HLA-A24 in complex with HIV-1 Nef134-10(wt) Heteromer
P61769; Q9YYU8;
3vxn25-298
Assess
HIV RT derived peptide complexed to HLA-A*0301 Heteromer
P61769; Q9YV12;
3rl125-298
Assess
Newly identified epitope V60 from HBV core protein complexed with HLA-A*0201 Heteromer
P61769; Q9QAC5;
4k7f26-299
Assess
HLA-A24 in complex with HIV-1 Nef126-10(8T10F) Heteromer
P61769; Q77378;
3wlb25-298
Assess
Crystal Structure of HLA A*0101 in complex with NP44-S7N, an 9-mer influenza epitope Heteromer
P61769; Q07FI1;
4nqx25-298
Assess
Crystal structure of RQA_V phosphopeptide bound to HLA-A2 Heteromer
P33241; P61769;
EDO;NA;4no225-298
Assess
Crystal Structure of HLA-A*0201 in complex with M1-F5L Heteromer
P61769;
5hhn25-298
Assess
HLA*A2402 complexed with HIV nef138 Y2F mutant 10mer epitope Heteromer
P04601; P61769;
5hgd25-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide G4M-V… Heteromer
P61769; Q03463;
3mri25-298
Assess
Crystal structure of the binary complex between HLA-A2 and HCMV NLV-T8V peptide variant Heteromer
P61769;
3gsx25-298
Assess
Crystal Structure of HLA-A*0201 in complex with M1-L3W Heteromer
P61769;
5hhq25-298
Assess
PF6-M1-HLA-A2 Heteromer
P03485; P61769;
5euo25-298
Assess
Crystal structure of PKD2 phosphopeptide bound to HLA-A2 Heteromer
P61769; Q9BZL6;
CD;GOL;4nnx25-298
Assess
Crystal structure of the binary complex between HLA-A2 and HCMV NLV-M5S peptide variant Heteromer
P61769;
3gsq25-298
Assess
Crystal structure of HLA-A1:MAGE-A1 in complex with Fab-Hyb3 Heteromer
P43355; P61769;
GOL;1w7225-298
Assess
HLA*A2402 complex with HIV nef138 Y2F-8mer mutant epitope Heteromer
P04601; P61769;
5hga25-298
Assess
Crystal Structure Analysis of NY-ESO-1 epitope, SLLMWITQC, in complex with HLA-A2 Heteromer
P61769; P78358;
SO4;1s9w25-298
Assess
Crystal Structure of KMD Phosphopeptide Bound to Human Class I MHC HLA-A2 Heteromer
P61769; Q86UW6;
EDO;3bhb25-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant Heteromer
P61769; Q16655;
3mrq25-298
Assess
Crystal Structure of HLA-A*2402 in complex with avian influenza A(H7N9) virus-derived peptide H7-25… Heteromer
A0A0X9JHC1; P61769;
5wwj25-298
Assess
Crystal Structure of HLA-A*2402 in complex with avian influenza A(H7N9) virus-derived peptide H7-25… Heteromer
A0A0X9JHC1; P61769;
5wxc25-298
Assess
HLA-A24 in complex with HIV-1 Nef134-8(2F) Heteromer
P04601; P61769;
4wu725-298
Assess
Crystal structure of LMP2 peptide from EBV in complex with HLA-A*11:01 Heteromer
P13285; P61769;
GOL;5gsd25-298
Assess
Crystal Structure Analysis of NY-ESO-1 epitope analogue, SLLMWITQS, in complex with HLA-A2 Heteromer
P61769;
SO4;1s9y25-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with EBV bmlf1-280-288 nonapeptide T4P v… Heteromer
P61769; Q3KSU1;
3mrf25-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS4b-1807-1816 decapeptide Heteromer
P61769; Q9DIT6;
3mrn25-298
Assess
HIV Nef derived peptide Nef73 complexed to HLA-A*0301 Heteromer
P04601; P61769;
3rl225-298
Assess
Crystal Structure of HLA A*0101 in complex with NP44, an 9-mer influenza epitope Heteromer
P03466; P61769;
4nqv25-298
Assess
Recognition of peptide-MHC by a V-delta/V-beta TCR Heteromer
P61769; Q9YYU8;
3nfn25-298
Assess
HLA*A2402 complexed with HIV nef138 10mer epitope Heteromer
P04601; P61769;
5hgh25-298
Assess
Structure of HLA-A68 complexed with an HIV derived peptide Heteromer
P61769; Q9YXY3;
4hwz25-298
Assess
Crystal Structure of HLA-A*2402 Complexed with a Newly Identified Peptide from 2009 H1N1 PA (649-65… Heteromer
P61769; Q9YXL3;
4f7m25-298
Assess
MAGE-A3 Reactive TCR in complex with Titin Epitope in HLA-A1 Heteromer
A0A0B4J279; A0A578; A0A5B9; P01848; P61769; Q8WZ42;
GOL; 11×SO4;5bs025-298
Assess
HLA*A2402 complexed with HIV nef138 8mer epitope Heteromer
P04601; P61769;
5hgb25-298
Assess
Newly identified epitope N1 derived from SARS-CoV N protein complexed with HLA-A*2402 Heteromer
P59595; P61769;
3i6l25-298
Assess
HLA-A24 in complex with HIV-1 Nef134-8(wt) Heteromer
P04601; P61769;
4wu525-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide N3S v… Heteromer
P61769; Q03463;
3mrh25-298
Assess
The complex between H27-14 TCR and HLA-A24 bound to HIV-1 Nef134-10(wt) peptide Heteromer
P61769; Q9YYU8;
3vxr25-298
Assess
Crystal Structure of HLA-A*1101 in complex with H1-22, an influenza A(H1N1) virus epitope Heteromer
P61769; P68043;
4mj525-298
Assess
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide C6V v… Heteromer
P61769; Q03463;
3mrl25-298
Assess
Human Class I MHC HLA-A2 in complex with synthetic peptide MMWDRGLGMM Heteromer
P61769;
6amt25-298
Assess
Crystal structure of killer cell immunoglobulin-like receptor KIR2DS2 in complex with HLA-A Heteromer
P43631; P61769; Q76ZQ3;
4n8v25-298
Assess
Crystal Structure Analysis of NY-ESO-1 epitope analogue, SLLMWITQA, in complex with HLA-A2 Heteromer
P61769;
SO4;1s9x25-298
Assess
HLA-A24 in complex with HIV-1 Nef134-10(6L) Heteromer
P61769; Q9WPU2;
3vxp25-298
Assess
The complex between C1-28 TCR and HLA-A24 bound to HIV-1 Nef134-10(2F) peptide Heteromer
P61769; Q9YYU3;
CO;3vxm25-298
Assess
Engineered Human HLA_A2 MHC Class I molecule in complex with TCR and SV9 peptide Heteromer
P61769;
GOL;ACT;6q3s25-298
Assess
Structure of HLA-A2:01 with peptide Y9L Heteromer
P61769;
GOL;5f9j25-298
Assess
Crystal Structure of HLA-A*1101 in complex with H7-22, an influenza A(H7N9) virus epitope Heteromer
P61769; Q9Q0U8;
4mj625-298
Assess
Crystal structure of a MHC class I-peptide complex Heteromer
P60201; P61769;
2xpg25-298
Assess
COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201 Heteromer
A0A075B6T6; A0A0K0K1A5; A0A5B9; P01848; P14079; P61769;
EMC;1ao725-298
Assess
The complex between T36-5 TCR and HLA-A24 bound to HIV-1 Nef134-10(2F) peptide in space group P2121… Heteromer
P61769; Q9YYU3;
3w0w25-298
Assess
HLA-A24 in complex with HIV-1 Nef134-10(2F) Heteromer
P61769; Q9YYU3;
3vxo25-298
Assess
MAGE-A3 reactive TCR in complex with MAGE-A3 in HLA-A1 Heteromer
A0A0B4J279; A0A578; A0A5B9; P01848; P43357; P61769;
SO4;5brz25-298
Assess
Crystal structure of peptide-HLA-A24 bound to S19-2 V-delta/V-beta TCR Heteromer
P03407; P61769;
5xov25-298
Assess
Structure of HLA-A2:01 with peptide Y10L Heteromer
P61769;
GOL;5fdw25-298
Assess
Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances af… Heteromer
P01848; P01850; P61769; P78358;
2f5425-298
Assess
The complex between T36-5 TCR and HLA-A24 bound to HIV-1 Nef134-10(2F) peptide Heteromer
P61769; Q9YYU3;
3vxu25-298
Assess
Crystal Structure of HLA-A*2402 in complex with 2009 pandemic influenza A(H1N1) virus and avian inf… Heteromer
A0A0X9JHC1; P61769;
5wwu25-298
Assess
Plasticity of human CD8 binding to peptide-HLA-A*2402 Heteromer
P01732; P61769; Q9YYU8;
3qzw25-298
Assess
Structure of HLA-A68 complexed with an HIV Env derived peptide Heteromer
P61769; Q70626;
4i4825-298
Assess
STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A Heteromer
P01848; P61769;
1qsf25-298
Assess
CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A Heteromer
P01848; P61769;
1qrn25-298
Assess
STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R Heteromer
P61769;
1qse25-298
Assess
Crystal structure of the public RA14 TCR in complex with the HCMV dominant NLV/HLA-A2 epitope Heteromer
P01848; P61769;
SO4;CL;3gsn25-298
Assess
Crystal Structure of HLA-A*11:01-GTS3 Heteromer
P61769; Q6YMS4;
K;5wjn25-298
Assess
The complex between TCR JKF6 and human Class I MHC HLA-A2 presenting the MART-1(27-35)(A27L) peptide Heteromer
P61769; Q16655;
4eup25-298
Assess
D30 TCR in complex with HLA-A*11:01-GTS1 Heteromer
P17763; P61769;
5wkf25-298
Assess
Crystal structure of an anaplastic lymphoma kinase-derived neuroblastoma tumor antigen bound to the… Heteromer
P61769; Q9UM73;
6at925-298
Assess
Crystal Structure of HLA-A*11:01 with GTS1 peptide Heteromer
P17763; P61769;
CL;5wjl25-298
Assess
Crystal Structure of HLA-A*2402 in complex with avian influenza A(H7N9) virus-derived peptide H7-25… Heteromer
A0A0X9JHC1; P61769;
5wwi25-298
Assess
D30 TCR in complex with HLA-A*11:01-GTS3 Heteromer
P61769; Q6YMS4;
5wkh25-298
Assess
Crystal Structure of HLA-A*2402 in complex with avian influenza A(H7N9) virus-derived peptide H7-25… Heteromer
A0A0X9JHC1; P61769;
5wxd25-298
Assess
Crystal structure of TCR C7 in complex with HCMV NLV epitope presented by HLA-A2 Heteromer
P18139; P61769;
5d2l26-299
Assess
Crystal structure of TCR PF8 in complex with flu MP(58-66) epitope presented by HLA-A2 Heteromer
P03485; P61769;
5e6i25-298
Assess
MHC-I complex with NRAS Q16K mutation determined by NMR Heteromer
P01111; P61769;
6mpp25-298
Assess
Structure of the human PLC editing module Heteromer
O15533; P27797; P30101; P61769;
NAG;MAN;6eny25-298
Assess
Structure of HLA-A2:01 with peptide G9V Heteromer
P61769;
GOL;5fa326-298
Assess
Crystal structure of C25-NLV-HLA-A2 complex Heteromer
P18139; P61769;
IMD;5d2n26-298
Assess
Structure of HLA-A2:01 with peptide G13E Heteromer
P61769;
5eot26-298
Assess
Crystal structure of DMF5 TCR bound to HLA-A2 presenting synthetic peptide MMWDRGLGMM Heteromer
P61769;
6amu26-298
Assess
Structure of HLA-A2:01 with peptide G11N Heteromer
P61769;
GOL;5f7d26-298
Assess
Structure of HLA-A2:01 with peptide Y16R Heteromer
P61769;
GOL;NA;5fa426-298
Assess
Crystal structure of 1406 TCR bound to HLA-A2 with HCV 1406-1415 antigen peptide Heteromer
P27958; P61769;
5jzi25-296
Assess
Crystal structure of a complex between the Human adenovirus type 4 E3-19K protein and MHC class mol… Heteromer
P14079; P61769; Q8BEL5;
5iro25-295
Assess
DIFFERENT LENGTH PEPTIDES BIND TO HLA-AW68 SIMILARLY AT THEIR ENDS BUT BULGE OUT IN THE MIDDLE Heteromer
P61769;
ALA;ARG;1hsb25-294
Assess
HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2.1 Heteromer
P61769;
3hla25-294
Assess
SPECIFICITY POCKETS FOR THE SIDE CHAINS OF PEPTIDE ANTIGENS IN HLA-AW68 Heteromer
P61769;
2hla25-294
Assess
STRUCTURE OF THE HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN, HLA-A2 Heteromer
P61769;
1hla25-294
Assess
Crystal Structure of the JM22 TCR in complex with HLA-A*0201 in complex with M1-F5L Heteromer
A0A075B6N1; A0A087WT01; A0A5B9; P01848; P61769;
5hhm25-269
Assess
THE THREE-DIMENSIONAL STRUCTURE OF A CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE MISSING THE … Heteromer
P61769;
1tmc25-199
Assess
HIV-1 Nef in complex with MHC-I cytoplasmic domain and Mu1 adaptin subunit of AP1 adaptor (second d… Heteromer
P35585; Q90VU7;
4emz338-356
Assess
Structure of HLA-DR1 with a bound peptide with non-optimal alanine in the P1 pocket Heteromer
P01903; P01911;
4ov5128-141
Assess
HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED… Heteromer
P01903; P01911;
1aqd128-141
Assess
HIV-1 Nef in complex with MHC-I cytoplasmic domain and Mu1 adaptin subunit of AP1 adaptor (second d… Heteromer
P35585; Q90VU7;
4en2343-354
Assess
Structure of the HLA-E-VMAPRTLVL/GF4 TCR complex Heteromer
P13747; P61769;
5w1w3-11
Assess
HLA-A*0201 single chain trimer with HPV.16 E7 peptide LLMGTLGIVmonomer 6apn26-298
Assess
HLA-A*0201 single chain trimer with murine H2K alpha 3 domain and HPV.16 E7 peptide YMLDLQPETmonomer 6e1i25-291
Assess

Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANTemplateRangeSeq id (%)
Isoform 2monomer0.856at5.1.A25-299
86.19
Assess